Artann Laboratories

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Artann Laboratories sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials none currently recruiting 14 completed top decile by trial count

Artann Laboratories: 14 sponsored US clinical trials, none currently recruiting.

Artann Laboratories sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 14 completed. The most-studied condition in this pipeline is Compare Performance of Colonoscopists, with 1 trials.

Top-decile sponsor footprint

Artann Laboratories ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

14 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

14 total, page 1 of 1

COMPLETED

Vaginal Tactile Imaging for Pelvic Floor Prolapse

NCT02925585
COMPLETED

Hydration Monitor Validation in Elderly

NCT02206633
COMPLETED

Using Hydration Monitor to Detect Changes in the Hydration Status Athletes

NCT02206581
COMPLETED

Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions

NCT02294383
COMPLETED

Effect of Anesthesia on Force Application During Colonoscopy

NCT02101099
COMPLETED

Study With Advanced Vaginal Tactile Imager

NCT01848626
COMPLETED

Validation of Transvaginal Tactile Imaging

NCT01491334
COMPLETED

Bone UltraSonic Scanner (BUSS): Validation Study

NCT01439139
COMPLETED

Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment

NCT01123421
COMPLETED

Development Study Using Vaginal Tactile Imager

NCT01111916
COMPLETED

Bone UltraSonic Scanner (BUSS) Clinical Optimization Study

NCT01056432
COMPLETED

Characterize Differences in Force Patterns Used by Different Endoscopists and Trainee Endoscopists

NCT01029899
COMPLETED

Prostate Mechanical Imager (PMI) Clinical Bridging Study

NCT00822952
COMPLETED

Evaluation of Handheld Colonoscopy Force Monitor by Expert Endoscopists in the Performance of Colonoscopy

NCT00797914

Therapeutic Areas

Compare Performance of Colonoscopists 1
Outpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic Diseases 1
Identify Characteristics of Colonoscopists During Endoscopy 1
Prostatic Hyperplasia 1
Dehydration 1
Pelvic Organ Prolapse 1
Prostatic Neoplasms 1

How the Artann Laboratories archive is shaped

14 indexed studies, none listed as recruiting (0% open); 14 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Compare Performance of Colonoscopists (1 trial), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Artann Laboratories: archived-pipeline peers nationwide

Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Artann Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Artann Laboratories3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA10xBio22nd Century Group23andMe3 Waves Wellness
Artann Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Artann Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Artann Laboratories page

14 registered trials is a research-attention snapshot, not an endorsement of Artann Laboratories or any single study.

  • None of Artann Laboratories's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Compare Performance of Colonoscopists is the condition Artann Laboratories studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Compare Performance of Colonoscopists trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Artann Laboratories pipeline card: 14 registered trials from official public datasets.Report a data error.